ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0553

The US Prevalence of Ulcerative Colitis Associated Peripheral Arthralgias and Arthritis: Data from the National Health & Nutrition Examination Survey (NHANES)

Oleg Stens1, Hyun-seok Kim2, Jason Hou2 and Michael Weisman3, 1Harbor-UCLA Medical Center, San Diego, CA, 2Baylor College of Medicine, Houston, TX, 3Cedars Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA

Meeting: ACR Convergence 2020

Keywords: Epidemiology, Spondylarthropathies, Ulcers

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 7, 2020

Title: Epidemiology & Public Health Poster II: OA, Osteoporosis, & Other Rheumatic Disease

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: An association between ulcerative colitis (UC) and peripheral arthritis has been known since the 1930’s and more recently has been described as a part of the spectrum of peripheral Spondyloarthritis (p-SpA). Prevalence rates of p-SpA in UC have been reported with varying estimates from clinical and cohort studies. To our knowledge there are no US population-based studies to estimate the prevalence of UC-associated peripheral arthritis or arthralgia. We describe herein population-based rates of peripheral arthritis and arthralgia among those with and without UC using previously unreported data from NHANES II (1976-80), a nationally-representative survey of the US population.

Methods: NHANES II participants ages 20-69 were interviewed and examined by physicians at mobile examination centers and defined as having UC if they reported having been diagnosed with UC by a physician. Previous analysis of NHANES II and NHANES 2009-10 data showed these self-reports to be consistent with true UC given corresponding high rates of colonoscopy, surgery, UC-related comorbidities, and UC-related symptoms.

Interview data was collected for a present or past history of peripheral arthralgias for ≥6 weeks (Table 1) and of arthritis signs and symptoms (arthralgias plus joint swelling and tenderness for ≥1 month) (Table 2). A physician joint exam was also performed (Table 3). Statistical analysis used SASTM 9.4 using survey design variables and sample weights to produce nationally representative estimates.

Results: 10,404 participants were interviewed and examined, 131 with a history of UC. 34% of those with UC reported present or past peripheral arthralgias (an estimated 400,000 persons nationwide) compared to 21% of those without (p=0.01). Rates of overall present or past polyarticular arthralgias, and of arthralgias at the hand and wrist, elbow, shoulder, hip, knee, and foot and ankle were all elevated among those with UC (all p< 0.05) (Table 1). 20% of participants with UC reported present or past peripheral arthritis compared to 11% without (p=0.02; Table 2). Rates of arthritis at the hand and wrist and knee were significantly elevated in UC (p< 0.05 for both). Rates of arthritis at the elbow, shoulder, hip, and foot and ankle were all elevated, but sample size precluded statistical evaluation (Table 2).

Overall, those with UC had significantly increased exam findings (28% vs. 12% without; p=0.03), notably increased pain on passive joint motion (12% with UC vs. 7% without; p=0.03). The rates of joint swelling on exam were similarly low in both groups (Table 3). On exam, Heberden’s Node prevalences were similar between both groups.

Conclusion: Rates of self-reported peripheral arthralgia and arthritis were elevated in NHANES II participants who reported a history of UC compared to the general population. However, while rates of joint pain with motion on exam were elevated in UC, rates of examination-based swelling were not. This may suggest that much of much of UC patients’ joint pain is due to peri-articular structure involvement, including possible tenosynovitis and enthesitis, and that point-prevalence of true arthritis is low consistent with p-SpA patients.


Disclosure: O. Stens, None; H. Kim, None; J. Hou, Redhill Biopharma, 2, Janssen, 2, 5, Abbvie, 2, 5, Celgene, 2, Genentech, 2, Eli Lilly, 2, Lycera, 2, Pfizer, 2, 5; M. Weisman, Novartis, 5, GSK, 5, UCB, 5, Lilly, 5.

To cite this abstract in AMA style:

Stens O, Kim H, Hou J, Weisman M. The US Prevalence of Ulcerative Colitis Associated Peripheral Arthralgias and Arthritis: Data from the National Health & Nutrition Examination Survey (NHANES) [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/the-us-prevalence-of-ulcerative-colitis-associated-peripheral-arthralgias-and-arthritis-data-from-the-national-health-nutrition-examination-survey-nhanes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-us-prevalence-of-ulcerative-colitis-associated-peripheral-arthralgias-and-arthritis-data-from-the-national-health-nutrition-examination-survey-nhanes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology